Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DEBRA

Financiado

Cerrado

Detection of Brain Abnormality

Cerebrovascular disease (CVD) is a very significant health problem, especially in view of the increasing aging population. It is highly prevalent in diabetic populations and is also a major cause of dementia, individually or as an... ver más

31/03/2012

UNIVERSITY OF PATR...

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

PANEPISTIMIO PATRON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2012-03-31 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UNIVERSITY OF PATRAS

0.00€ | Lider

Proyectos interesantes

TEC2009-14587-C03-02

Medical Technol...

Data Science

70K€ Cerrado

TEC2009-14587-C03-01

Medical Technol...

Data Science

108K€ Cerrado

TIN2014-55710-R

Medical Technol...

Data Science

148K€ Cerrado

DEMO

Medical Technol...

Data Science

853K€ Cerrado

TRABIT

Medical Technol...

Data Science

4M€ Cerrado

ARTEMIS

Medical Technol...

Data Science

240K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

PANEPISTIMIO PATRON No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 75K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cerebrovascular disease (CVD) is a very significant health problem, especially in view of the increasing aging population. It is highly prevalent in diabetic populations and is also a major cause of dementia, individually or as an additive factor to other pathologies, such as Alzheimer’s. Therefore measuring disease burden, progression, and response to treatments is very important for patient management. MRI is currently the most widely used way to characterize in vivo the type and extent of brain lesions in CVD and has been used in several large neuroimaging studies. However, characterization of CVD has largely relied on qualitative, subjective, and not easily reproducible methods of human expert-based interpretation. Computer-based methods for measuring CVD offer great potential, since they are quantitative; reproducible, and particularly suitable for longitudinal studies monitoring disease progression and response to candidate treatments. Most methods have focused on the segmentation of Multiple Sclerosis lesions, whereas less attention has been given to brain lesion segmentation in elderly individuals and Alzheimer’s disease or diabetic patients. The project DeBrA (Detection of Brain Abnormality) includes the development and implementation of medical imaging techniques for measuring CVD and its change over time, from multi-parametric MR images by employing advanced 4-dimensional (space X time) segmentation methods based on pattern classification and statistical modeling. The goal is to determine whether the new methodology will provide more stable measurements of longitudinal change in CVD, compared to relatively more conventional methods and therefore increase the sensitivity of detecting subtle effects. Moreover, while the tools will be initially developed for measuring CVD, they will be made suitable to hold widespread potential for applications in other neuroimaging studies involving abnormality detection.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores